Creative Biolabs-Immuno-oncology

Anti-EGP2 (clone 4IA7J) SynExpress E1-mKa-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR2609)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGP2 (clone 4IA7J). We employs the Lentivirus (EF1α-mKate-c-Jun-KpnI) vector components and the SynExpress system of the Multiple base pair Insertion/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EGP2
Clone
4IA7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
EF1α
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Insertion
Modification Domain
Multiple base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.98
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.